Our Investment Process

At the AI Biotech Fund, we follow a systematic, data-driven approach to identify and capitalize on high-potential investment opportunities in the biotech sector. By combining advanced AI insights, rigorous analysis, and expert validation, we ensure every decision is guided by precision and discipline.

Step-by-Step Investment Process

Step 1:

Data Collection

We collect vast amounts of data on clinical trial inflection points, including announcements related to trial outcomes, partnerships, and special designations. Leveraging Large Language Models (LLMs), we process and analyse this information alongside stock price reactions for hundreds of biotechs. This foundational dataset forms the backbone of our investment model.

Step 2:

Step 3:

Step 4:

Step 5:

Step 6:

Why Our Process Stands Out

Data-Driven Insights

Advanced AI and TrialKey analytics
guide every decision.

Targeted Precision

Focused on pivotal moments in clinical trials to optimize outcomes.

Rigorous Validation

Human expertise ensures the reliability of model recommendations.

Comprehensive Analysis

From market trends to company fundamentals, no detail is overlooked.

Learn More

Want to see how our process works in action? Request the Information
Memorandum or schedule a call with our team today.

Contact Us

Get in touch to discuss investment opportunities and insights.

Harnessing AI to transform biotech investment strategies.

AI Biotech Fund Pty Ltd ACN 158 314 982 is a Corporate Authorised Representative (CAR No. 1312461) of Non Correlated Advisors Pty Ltd (AFSL No. 430126) and is authorised to provide general advice only to wholesale investors.

info@aibiofund.com

Sign up to receive monthly newsletter